Fingerprint
Dive into the research topics of 'Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy
Yasmin Yu*, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D. Smith, Daniel L. Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review
3
Citations
(Scopus)